KRKerstin Rödström

Kerstin Rödström

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kerstin Rödström has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reproducibility of self-reported menopause age at the 24-year follow-up of a population study of women in Göteborg, Sweden

    by Kerstin Rödström, Calle Bengtsson, Lauren Lissner, Cecilia Björkelund

    To study the reproducibility of self-reported age at natural menopause, reported by women in their 70s, compared with menopause age reported in the initial postmenopausal period. A prospective study conducted in Göteborg, Sweden, based on a random sample of the total female population, started in 1968-1969, with follow ups in 1974-1975, 1980-1981, and 1992-1993. A total of 1,009 women born in 1922, 1918, or 1914 (participation rate 90.3%), representative of women of the respective ages in the general population, participated in the initial examination in 1968-1969. Of those women reporting natural menopause some time between 1968 and 1981, 565 women recalled their menopause age in 1992. The mean interval between the first and second reports was 18.3 years. The mean difference between first-reported and recalled menopause was 0.05 years. When menopause age was recalled in 1992-1993, 55.6% of the women with a natural menopause recalled their age at menopause correctly within 1 year, 22.6% underestimated their menopause age by more than 1 year, and 21.8% overestimated their menopause age by more than 1 year. Women undergoing early menopause (55 years) tended to underestimate menopause age. These differences could not be explained by age, interval since menopause, smoking, exercise, education, or socioeconomic status. Menopause ages reported at an interval of almost 20 years showed a significant correlation. However, a regression tendency of the values toward the mean was observed, suggesting that strong correlation at the group level does not imply precision at the extremes.


  • Evidence for a secular trend in menopausal age: a population study of women in Gothenburg

    by Kerstin Rödström, Calle Bengtsson, Ian Milsom, Lauren Lissner, Valter Sundh, Cecilia Bjoürkelund

    To describe secular trends in age of natural menopause. A prospective study based on a random sample of the total female population in Gothenburg, Sweden, started in 1968 with follow-ups in 1974-75, 1980-81, 1992-93, and 2000-02. 1,462 women born in 1930, 1922, 1918, 1914, and 1908 (participation rate, 90.1%) representative of women of the same ages in the general population. Information regarding menopausal age was provided by 1,373 of the 1,462 women (93.9%). The number was further reduced to 1,017 after exclusion of women who had taken hormones, undergone a surgical menopause, or both. The mean age at natural menopause showed a steady increase across birth cohorts. Trends were similar in women who had smoked and women who had never smoked, even after adjusting for different covariates. The upward trend was 0.1 years per birth year (SE 0.020, P < 0.0001). Interestingly, women with earlier menarche had a somewhat earlier age at menopause, independent of the cohort effect. When hormone users were included in the sample, the cohort effect was also found to be independent of oral contraceptive use and hormone therapy. This study has shown that, independent of variations in socioeconomic status, smoking status, oral contraceptive use, or hormone therapy use, as well as other potential confounders, there was a highly significant secular trend of increase in menopausal age. The observation of a positive association between menarche and menopausal age has, to our knowledge, not previously been described.


  • A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century

    by Kerstin Rödström, Calle Bengtsson, Lauren Lissner, Ian Milsom, Valter Sundh, Cecilia Björkelund

    Objective To describe the prevalence and treatment of hot flushes in premenopausal and postmenopausal women from the 1960s to the 1990s. Design This prospective study, based on a random sample of the total female population of 430,000 in Gothenburg, Sweden, was started in 1968, with follow-ups in 1974, 1980, and 1992. The participants were 1,462 women born in 1930, 1922, 1918, 1914, and 1908 (participation rate 90.1%) who were representative of women of the same age in the general population. For the purpose of analyzing secular trends, we included 122 participants who were 38 years old and 47 who were 50 years old in 1980–1981. Results The prevalence of hot flushes increased from ∼11% at 38 years to a maximal prevalence of ∼60% at 52 to 54 years of age, then declined successively from ∼30% at 60 years of age to ∼15% at 66 years of age, and then to ∼9% at 72 years of age. The predominant type of medication being prescribed changed during the observation period from sedatives/anticholinergic drugs in the 1960s to hormone replacement therapy in the 1980s. Hormone replacement therapy was considered to be an effective form of treatment for hot flushes by 70% to 87% of the women. Conclusions Hot flushes were a common symptom, with a maximal prevalence of 64% at 54 years of age. Medical consultation and treatment did not increase in 50-year-old women from 1968–1969 to 1980–1981. Treatment changed and became more effective during the observation period.


    • 14 February 2001
      • Vol. 98  (7) , 719-21

    [Comments to a proposal: "Specialists closely connected to primary health care" should be excellent generalists in the long run].

    by C Björkelund, C Lundh, B Mattsson, K Rödström, A Westerståhl

  • Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden

    by Kerstin Rödström, Calle Bengtsson, Lauren Lissner, Cecilia Björkelund

    Objective: To assess whether risk factor profiles for cardiovascular disease differed, before starting treatment, between women who would subsequently use hormone replacement therapy and those who would remain untreated. Design: Prospective population study, initiated in 1968-9, with follow ups in 1974, 1980 and 1992. Setting: Gothenburg, Sweden. Participants: 1201 women born in 1918, 1922 and 1930, representative of women of the same age in the general population. Main outcome measures: Hormone replacement therapy as a function of initial systolic and diastolic blood pressure, waist and hip circumference, waist to hip ratio, body mass index, serum concentrations of cholesterol and triglycerides, smoking status, education, leisure time activity, and socioeconomic group. Results: 179 of the 1202 women (14.9%) used hormone replacement therapy sometime during the 24 year follow up period. Multivariate models indicated that these women had significantly lower blood pressure, had less obesity, and belonged to a higher social group before the start of treatment than women who would remain untreated. Conclusion: Women who would subsequently use hormone replacement therapy were already at lower cardiovascular risk before the start of treatment than women who would remain untreated. Some of the claimed beneficial effects of treatment may thus be explained by women who would use hormone replacement therapy representing a healthier cohort than women who would remain untreated. Many retrospective epidemiological studies have shown that hormone replacement therapy reduces the risk of cardiovascular disease Results from the prospective population study in Gothenburg show that there were already differences in risk factor profile of women before hormone replacement therapy was considered It is too early to recommend hormone replacement therapy for prevention of cardiovascular disease before controlled randomised studies have been performed